Search

Dr Njoumemi Zakariaou

Dr Zakariaou is a health economist and obtained his Ph.D. in Public Health specialising in Health Economics from Health Economics Unit, School of Public Health and Family Medicine, Faculty of Health Science, University of Cape Town, South Africa.  He has an MSc in Health Economics from WHO Collaborating Centre for Health Economics, Faculty of Economics, Chulalongkorn University, Bangkok, Thailand. 

He is currently a senior lecturer/researcher in health economics, health policy and health systems, health care financing and management at the Department of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I. He is also the director of Health Economics & Policy Research and Evaluation for Development Results Group (HEREG), Yaoundé Cameroon.

Dr Zakariaou has participated as co-investigator in some operational research on financing, costing and cost-effectiveness of public health programmes in Africa, for example:

 – Evaluating the financial contribution of the state to the fight against the river blindness in Cameroon (2008 - 2010)

– Costing the community-directed interventions for major health problems in Africa: Onchocerciasis, Malaria, TB, and Vitamin A Deficiency through a multi-country study which involves Cameroon, Nigeria, Tanzania and Uganda funded by UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease (TDR)  (2003 - 2007) 

-  Evaluating and analysing the external monetary incentive policies for volunteers of community-based health programmes including: Onchocerciasis, Reproductive Health (Child and Maternal Health, Family Planning, population activities), Immunisation, HIV/AIDS and other STIs, Malaria, Tuberculosis, Nutrition, Schistosomiasis, Guinea Worm, Water and Sanitation, Epidemiological Surveillance, etc.) in Cameroon, Ethiopia, Nigeria and Uganda through a multi-country study funded by WHO/APOC (2007)

- Evaluating and analysing the global/total cost per project and unit cost per person treated with Ivermectin using the Community-Directed Treatment with Ivermectin (CDTI) Strategy in Cameroon, Nigeria and Uganda funded by WHO/APOC. (2004)

His special interest areas are health policy & systems research, health care financing & costing of health care programs, and monitoring & evaluation of health policy and health systems.